Pharos Capital Group has announced it has acquired a majority stake in RhythMedix.
RhythMedix, founded in 2013 and based in Mt. Laurel, N.J., is a manufacturer and provider of remote cardiac monitoring systems and related services.
Pharos, with offices in Dallas and Nashville, pursues control equity and mezzanine investments in lower and middle